Centre for Addiction and Mental Health

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: -

Established: 1998-01-01

Employees: -

Market Cap: -

Website: http://www.camh.ca/en/hospital/Pages/home.aspx

Clinical Trials

Prevention of Weight Gain in Early Psychoses

Not Applicable

Completed

Conditions: Schizophreniform Disorder
Bipolar I Disorder
Bipolar II Disorder
Psychosis Not Otherwise Specified
Schizophrenia
Schizoaffective Disorder
Substance-Induced Psychoses
Major Depressive Disorder

Interventions: Other: TAU
Behavioral: Behavioural Intervention for the Prevention of Weight Gain

First Posted Date: 2010-02-25

Last Posted Date: 2017-07-25

Lead Sponsor: Centre for Addiction and Mental Health

Target Recruit Count: 70

Registration Number: NCT01075295

Locations: 🇨🇦
Centre for Addiction and Mental Health, Toronto, Ontario, Canada

Distribution of Bupropion and Varenicline to Increase Smoking Cessation Attempts

Phase 4

Completed

Conditions: Smoking
Smoking Cessation
Tobacco Use Disorder

Interventions: Drug: varenicline
Drug: bupropion
Behavioral: motivational emails

First Posted Date: 2009-12-02

Last Posted Date: 2018-01-24

Lead Sponsor: Centre for Addiction and Mental Health

Target Recruit Count: 893

Registration Number: NCT01023659

Locations: 🇨🇦
Centre for Addiction and Mental Health, Toronto, Ontario, Canada

STOP Study: Effectiveness of Zyban in a Clinical Population

Phase 4

Completed

Conditions: Cigarette Smoking
Nicotine Addiction
Smoking Cessation

Interventions: Drug: bupropion HCl

First Posted Date: 2009-11-18

Last Posted Date: 2017-03-27

Lead Sponsor: Centre for Addiction and Mental Health

Target Recruit Count: 454

Registration Number: NCT01015170

Locations: 🇨🇦
West Durham Family Health Team, Pickering, Ontario, Canada
🇨🇦
Aberdeen Downtown Nurse Practitioner Clinic, Brantford, Ontario, Canada
🇨🇦
Summerville Family Health Team, Mississauga, Ontario, Canada

and more 20 locations

Effect of Varenicline on Reactivity to Smoking and Drinking Cues

Not Applicable

Completed

Conditions: Tobacco Dependence
Alcohol Dependence

Interventions: Drug: Placebo
Drug: Varenicline

First Posted Date: 2009-04-01

Last Posted Date: 2015-09-07

Lead Sponsor: Centre for Addiction and Mental Health

Target Recruit Count: 48

Registration Number: NCT00873535

Locations: 🇨🇦
Centre for Addiction and Mental Health, Toronto, Ontario, Canada

Cognitive Behavioral Social Skills Training for Patients With Late-Life Schizophrenia: a Pilot Study

Not Applicable

Completed

Conditions: Schizophrenia

Interventions: Behavioral: Treatment as usual (TAU)
Behavioral: CBSST plus treatment as usual

First Posted Date: 2009-01-30

Last Posted Date: 2021-02-17

Lead Sponsor: Centre for Addiction and Mental Health

Target Recruit Count: 80

Registration Number: NCT00832845

Locations: 🇨🇦
Centre for Addiction and Mental Health, Toronto, Ontario, Canada

Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia

Not Applicable

Conditions: Schizophreniform Disorder
Schizophrenia
Schizoaffective Disorder

Interventions: Drug: risperidone

First Posted Date: 2009-01-19

Last Posted Date: 2020-02-07

Lead Sponsor: Centre for Addiction and Mental Health

Target Recruit Count: 14

Registration Number: NCT00825045

Locations: 🇨🇦
Centre for Addiction and Mental Health, Toronto, Ontario, Canada

24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Study

Not Applicable

Completed

Conditions: Schizophrenia
Schizoaffective Disorder

Interventions: Drug: ziprazidone

First Posted Date: 2009-01-07

Last Posted Date: 2012-07-09

Lead Sponsor: Centre for Addiction and Mental Health

Target Recruit Count: 12

Registration Number: NCT00818298

Locations: 🇨🇦
Centre for Addiction and Mental Health - PET Centre, Toronto, Ontario, Canada

Stress Generation and Recurrent Depression: The Role of Differential Treatment Response

Phase 1

Completed

Conditions: Depression
Major Depressive Disorder

Interventions: Behavioral: Cognitive Behavioral Therapy
Behavioral: Interpersonal Therapy
Drug: Antidepressant medication

First Posted Date: 2008-09-01

Last Posted Date: 2008-09-01

Lead Sponsor: Centre for Addiction and Mental Health

Target Recruit Count: 72

Registration Number: NCT00745017

Locations: 🇨🇦
Centre for Addiction and Mental Health, Toronto, Ontario, Canada

Patient Dimensions as Predictors of Varied Treatment Responses and Outcomes in Patients With Major Depression

Phase 2

Completed

Conditions: Depression
Major Depressive Disorder

Interventions: Behavioral: Cognitive Behavioral Therapy
Behavioral: Interpersonal Therapy
Drug: Antidepressant medication (sertraline ,paroxetineor or venlafaxine)

First Posted Date: 2008-09-01

Last Posted Date: 2008-09-01

Lead Sponsor: Centre for Addiction and Mental Health

Target Recruit Count: 72

Registration Number: NCT00744406

Locations: 🇨🇦
Centre for Addiction and Mental Health, Toronto, Ontario, Canada

rTMS Effects on Smoking Cessation and Cognition in Schizophrenia

Not Applicable

Completed

Conditions: Schizophrenia
Cigarette Smoking

Interventions: Procedure: Sham Repetitive Transcranial Magnetic Stimulation (rTMS)
Procedure: Repetitive Transcranial Magnetic Stimulation (rTMS)

First Posted Date: 2008-08-18

Last Posted Date: 2012-12-05

Lead Sponsor: Centre for Addiction and Mental Health

Target Recruit Count: 15

Registration Number: NCT00736710

Locations: 🇨🇦
Centre for Addiction and Mental Health, Toronto, Ontario, Canada

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy